Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The combination treatment showed a higher response rate but no significant survival benefits.

MEK and BRAF inhibitors increase sebum production and accumulation, which could cause acne-like side effects.

Drugs targeting EMT molecules show promise for treating lichen planopilaris.

A bull with a gene mutation was asymptomatic, synthetic retinoids cause hair loss, and new therapeutic targets were identified for skin diseases.

Enzalutamide, a prostate cancer drug, may help prevent COVID-19 by blocking the virus from entering lung cells.

Hedgehog pathway inhibitors used for skin cancer can cause significant hair loss, which may improve after stopping the medication.

WYE-130600 may cause skin thickening and irritation.

Activating PPAR-γ signalling can protect hair follicle stem cells from damage caused by chemotherapy.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

Nano-liposome-bound EGF can delay hair growth in rats.

Targeting Keratin 17 may help overcome cancer therapy resistance.

Combining DEB-BACE with chemotherapy is more effective and has fewer side effects than chemotherapy alone for treating unresectable lung squamous cell carcinoma.

ALRN-6924 may prevent hair loss caused by chemotherapy.

PI3Kδ inhibition may effectively treat cutaneous chronic graft-versus-host disease.

Entospletinib effectively prevents eye and skin GVHD in mice.

The treatment combination is effective and generally safe for lung cancer.

The treatment was ineffective in humans.

AP-1 and TGFß work together to drive resistance in basal cell carcinoma, suggesting new treatment options.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

EGF and FGF signaling stops hair follicle development in mice.

EGCG may help regrow hair by inhibiting a specific enzyme.

Topical rapamycin may effectively treat fibrous papules on the face.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Ebastine may promote hair regrowth by increasing cell growth through the ERK pathway.

Targeting multiple pathways and understanding genetic mutations are crucial for effective melanoma therapy.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Targeted cancer therapies often cause skin side effects, needing dermatologist care.

The combination of encorafenib and binimetinib caused few skin issues.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

Potassium channel activators like nicotinamide and minoxidil might help treat solid tumors.